Found "Public health policy": 1,044 results
Variation of health-related quality of life assessed by caregivers and patients affected by severe childhood infections. (2013)
Variation of health-related quality of life assessed by caregivers and patients affected by severe childhood infections.
Wantanee KulpengEmail author, Vorasith Sornsrivichai, Virasakdi Chongsuvivatwong, Waranya Rattanavipapong, Pattara Leelahavarong, John Cairns, Yoel Lubell and Yot Teerawattanan
Economic costs of obesity in Thailand: a retrospective cost-of-illness study (2014)
Abstract (provisional)
Background
Over the last decade, the prevalence of obesity (BMI >= 25 kg/m2) in Thailand has been rising rapidly and consistently. Estimating the cost of obesity to society is an essential step in setting priorities for research and resource use and helping improve pu
HIV/AIDS health care challenges for cross-country migrants in low- and middle-income countries: a scoping review (2014)
Rapeepong Suphanchaimat1,2 Angkana Sommanustweechai1 , Chiraporn Khitdee1 , Chompoonut Thaichinda1 , Kanang Kantamaturapoj3 , Pattara Leelahavarong4 , Pensom Jumriangrit1 , Thitikorn Topothai1 , Thunthita Wisaijohn1
Weerasak Putthasri1
1International Health Policy Program (IHPP), Ministry of Publi
A Cost-Utility Analysis Comparing Standard Axillary Lymph Node Dissection with Sentinel Lymph Node Biopsy in Patients with Early Stage Breast Cancer in Thailand (2014)
Abstract
Objectives
In Thailand, axillary lymph node dissection (ALND) is the dominant form of treatment for breast cancer, even though the treatment often leaves patients with some degree of arm morbidity. Sentinel lymph node biopsy (SNB) is widely accepted globally as a preferable alternative pr
Health Care Coverage Decision Making in Low- and Middle-Income Countries: Experiences from 25 Coverage Schemes (2014)
Hialy Gutierrez, MPH,1,2 Ashwini Shewade, MS, MSc,1 Minghan Dai, MPH,1 Pedro Mendoza-Arana, MD, MSc,3 Octavio Go´mez-Dante´s, MD, MPH,4 Nishant Jain, PhD,5 Irma Khonelidze, MPA,6 Juliet Nabyonga-Orem, MD, MSc,7 Karima Saleh, PhD,8 Yot Teerawattananon, MD, PhD,9 Sania Nishtar, SI, PhD,10 and John Hor
Is diabetes and hypertension screening worthwhile in resource-limited settings? An economic evaluation based on a pilot of a Package of Essential Non-communicable (PEN) disease interventions in Bhutan. (2014)
In response to a lack of cost-effective data on screening and early treatment of diabetes and hypertension in resource-limited settings, a model-based economic evaluation was performed on the World Health Organization (WHO)’s Package of Essential Non-communicable (PEN) disease interventions for prim
Cost-utility analysis of adjuvant chemotherapy in patients with stage III colon cancer in Thailand. (2014)
Background: In Thailand, there has been no economic evaluation study of adjuvant chemotherapy for stage III colon cancer patients after resection. Objective: This study aims to evaluate the cost-utility of all chemotherapy regimens currently used in Thailand compared with the adjuvant 5-fluorouracil
Economic costs of obesity in Thailand: a retrospective cost-of-illness study (2014)
Abstract
Background: Over the last decade, the prevalence of obesity (BMI ≥ 25 kg/m2) in Thailand has been rising rapidly and consistently. Estimating the cost of obesity to society is an essential step in setting priorities for research and resource use and helping improve public awareness of th
Assessing the Accuracy and Feasibility of a Refractive Error Screening Program Conducted by School Teachers in Pre-Primary and Primary Schools in Thailand (2014)
Abstract
Introduction: As part of the development of a system for the screening of refractive error in Thai children, this study describes the accuracy and feasibility of establishing a program conducted by teachers.
Objective: To assess the accuracy and feasibility of screening by teachers.
A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand (2014)
Abstract
Background: Only lamivudine has been included for patients with chronic hepatitis B (CHB) in the National List of Essential Drugs (NLED), a pharmaceutical reimbursement list in Thailand. There have also been no economic evaluation studies of CHB drug treatments conducted in Thailand yet. I
10 / Page